1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
At its September 24, 2026 annual meeting, AMC stockholders did not approve three charter amendments, including declassifying the board, because each needed a majority of outstanding shares and fell short. Stockholders also rejected the non-binding say-on-pay vote, while approving an increase in the 2024 equity plan from 25,000,000 to 50,000,000 shares.
Declassification charter amendment (Proposal 1) received 361,713,796 For votes, 40.5% of shares outstanding, short of the majority required
Non-binding advisory vote on executive compensation failed, with 54.7% of votes cast against
Stockholders approved raising the 2024 equity incentive plan share limit from 25,000,000 to 50,000,000 shares
Denise M. Clark, Sonia Jain and Keri S. Putnam were elected as Class III directors with terms expiring at the 2029 annual meeting
Patriot National Bancorp agreed on September 23, 2026 to sell 4,782,608 shares of voting common stock at $1.15 per share to accredited investors in a registered direct offering, with no underwriter or placement agent. The company expects about $5.5 million in gross proceeds, less estimated offering expenses of $350,000, and plans to invest the capital in its subsidiary Patriot Bank NA and for general corporate purposes. The sale adds shares outstanding and includes five-year warrants for 956,522 non-voting common shares exercisable at $1.25, which may dilute existing shareholders.
Shares sold: 4,782,608 voting common shares at $1.15 each, dated September 23, 2026
Expected gross proceeds: approximately $5.5 million; estimated offering expenses: $350,000
Warrants: 956,522 five-year warrants, one for every five shares purchased, exercisable no earlier than six months after closing at $1.25 per share
Proceeds to fund Patriot Bank NA and general corporate purposes; offering made under an S-3 shelf effective May 22, 2025
Akamai entered two project plans under its existing Anthropic master services agreement, under which Anthropic has committed to pay about $11.6 billion over initial seven-year terms, subject to termination rights and delivery requirements. Akamai also issued Anthropic a warrant for Series B preferred stock that would convert into up to about 7.7 million common shares, roughly 5% of shares outstanding, with about 2% expected to vest on the initial commitment. Akamai said the deal is not expected to affect its 2026 revenue guidance but will raise 2026 capital expenditures by about $1.7 billion, and the filing's total capital expenditure estimate for the commitment is about $5.5 billion.
Anthropic has committed to pay about $11.6 billion in aggregate under Project Plans 2 and 3, each with an initial seven-year term, dated September 18, 2026
Warrant for 387,051 shares of Series B Non-Voting Convertible Preferred Stock, each convertible into 20 common shares, for up to 7,741,020 common shares on an as-converted basis
Total capital expenditures tied to the $11.6 billion commitment are estimated at about $5.5 billion, with about $1.7 billion more in 2026 capital expenditures for supply chain components including memory
Akamai anticipates no impact to its 2026 revenue guidance
AtlasClear reported fiscal 2026 results for the year ended June 30, 2026, with total revenue up 85% to $20.1 million. Net income was $2.0 million, or $0.02 per share, down from $5.8 million, or $0.96 per share, in fiscal 2025, and the loss from operations widened to $9.8 million, with the net result supported by non-cash fair-value gains.
Total revenue rose to $20.1 million from $10.9 million, with stock locate revenue at $6.8 million versus $0.3 million
Loss from operations was $9.8 million, compared with $4.9 million in fiscal 2025
Net income was $2.0 million, including an $11.1 million non-cash gain on the earnout liability; fiscal 2025 net income was $5.8 million
Cash and cash equivalents totaled $15.4 million at June 30, 2026, versus $7.5 million a year earlier
TTM Technologies completed a $500 million private offering of 6.750% senior notes due 2034 on September 24, 2026. Proceeds, along with $300 million and $800 million of incremental term loans, are intended to fund the pending acquisition of EDS Intermediate Holding, LLC and related costs, with some funds possibly used to reduce revolver borrowings for the Swiss Technology Group AG acquisition. The filing adds substantial new debt and restricts dividends and other payments to shareholders, and the notes become subject to mandatory redemption if the EDS acquisition does not close by the November 15, 2026 outside date, subject to extension.
$500 million of 6.750% senior notes due October 1, 2034, priced at par and issued September 24, 2026
Planned financing also includes a $300 million incremental term loan A and an $800 million incremental term loan B
Notes must be redeemed at 100% of principal plus interest if the EDS acquisition does not close by November 15, 2026 (extendable to May 15, 2027 in certain cases)
Indenture limits dividends, share repurchases and certain other payments to shareholders
Trio-Tech International reported fiscal 2026 revenue of $62.6 million, up 72% from $36.5 million, with a fiscal 2026 net loss attributable to common shareholders of $34,000 versus $41,000 in fiscal 2025. Fourth-quarter revenue rose about 40% to $14.9 million, but the company posted a net loss of $199,000 after net income of $183,000 a year earlier, and gross margin fell to 19% from 25%.
Fiscal 2026 revenue was $62.6 million, with Semiconductor Back-end Solutions revenue up 99% to $49.0 million.
Fourth-quarter operating loss was $266,000, compared with operating income of $467,000 a year earlier.
Total backlog was $24.2 million at June 30, 2026, compared with $11.0 million a year earlier.
Fiscal 2027 first-quarter bookings to date in Industrial Electronics total about $4.6 million, according to the company.
RAVE Restaurant Group reported fourth-quarter and fiscal 2026 results for the year ended June 28, 2026. Fourth-quarter revenue rose to $3.4 million while net income fell 6.2% to $0.8 million, but full-year net income rose to $2.9 million from $2.7 million. The filing also discloses that CEO Brandon Solano sent a complaint on August 31, 2026, alleging workplace harassment and discrimination by the Board, and that the company engaged Hagan Law Group on September 1, 2026 to investigate.
Q4 fiscal 2026 total revenue increased $0.3 million to $3.4 million, up 8.8% year over year; net income was $0.8 million, down 6.2%
Fiscal 2026 net income was $2.9 million ($0.20 per diluted share) versus $2.7 million ($0.19) in fiscal 2025; revenue was $12.9 million
Pie Five domestic comparable store sales fell 17.3% in Q4 and 9.9% for the year; Pizza Inn comparable sales rose 2.4% for the year
On August 31, 2026, CEO Brandon Solano sent a complaint to the Audit Committee Chairman; Hagan Law Group was engaged September 1, 2026 to investigate
New Era Energy & Digital, Inc. entered into a sales agreement allowing it to sell up to $100 million of common stock through several agents over time, with no obligation to sell any shares. The company also disclosed that a Texas order halting data center permits could delay permits needed for its TCDC and other projects, and that it is negotiating with potential tenants, including an anchor tenant for its flagship project.
Up to $100 million of common stock may be sold through six agents under the Sales Agreement dated September 24, 2026.
Agents receive a commission of up to 3.5% of gross proceeds from each sale, plus reimbursement of legal fees.
Proceeds are intended for general corporate purposes, which may include capital expenditures, working capital and debt repayment.
On September 21, 2026, Texas Governor Greg Abbott directed the Texas Commission on Environmental Quality to halt data center permits until an ERCOT audit is complete.
On September 23, 2026, HCW Biologics agreed to sell 903,614 units to an existing institutional investor for approximately $1.5 million in gross proceeds before offering expenses. Each unit pairs a pre-funded warrant with the right to receive a common warrant at $1.66 per share, which is issuable only after stockholder approval that the company is obligated to seek. The company plans to use the proceeds for working capital, clinical development and general corporate purposes, and it agreed to register the resale of the shares underlying the warrants, which could add shares to the market.
903,614 units sold at $1.6599 per unit; pre-funded warrants have a $0.0001 exercise price
Common warrants for up to 903,614 shares, exercisable at $1.66 per share for 5.5 years after issuance, subject to stockholder approval under Nasdaq Rule 5635(d)
Maxim Group LLC is the sole placement agent
Company must file a resale registration statement within 15 trading days after closing and use commercially reasonable efforts to have it declared effective within 60 days
aTyr Pharma said it has reached alignment with the FDA on the protocol for a planned Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease. The company expects to start study-related activities in the fourth quarter of 2026 and to focus on regulatory submissions in the U.S. and Europe, but the filing states that future development will require additional capital through equity or debt offerings, grant funding, collaborations, partnerships or licensing.
Planned 54-week, randomized, double-blind, placebo-controlled study of up to approximately 372 patients
Efzofitimod 5.0 mg/kg or placebo given intravenously once every 3 weeks for a total of 17 doses
Primary endpoint is change from baseline in forced vital capacity at week 48; key secondary endpoint is King's Sarcoidosis Questionnaire-Lung score
Study-related activities expected to begin in the fourth quarter of 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.